Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PIEZO1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PIEZO1 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 510 entities in the SciDEX knowledge graph.
| Gene Symbol | PIEZO1 |
| Full Name | Piezo Type Mechanosensitive Ion Channel Component 1 |
| Chromosome | 16q24.3 |
| Protein Type | Ion Channel |
| Target Class | Ion Channel |
| Function | Small molecule modulator of mechanosensitive ion channel activity |
| Mechanism of Action | Small molecule modulator of mechanosensitive ion channel activity |
| Primary Expression | microglia, astrocytes, and brain endothelial cells, where it transduces mechanical cues from the ti |
| Druggability | Low (0.42) |
| Clinical Stage | Phase I |
| Molecular Weight | 286 kDa |
| Amino Acids | 521 aa |
| Exons | 51 |
| Pathways | Angiogenesis, Apoptosis, Autophagy, Calcium Signaling, Epigenetic |
| UniProt ID | Q9H5I5 |
| NCBI Gene ID | 9780 |
| Ensembl ID | ENSG00000103335 |
| OMIM | 611184 |
| GeneCards | PIEZO1 |
| Human Protein Atlas | PIEZO1 |
| Associated Diseases | Als, Alzheimer, Atherosclerosis, Bacterial Infection, Cancer, Cardiovascular |
| Known Drugs/Compounds | Yoda1, artemisinin, Paeoniflorin |
| Interactions | KCNK2, IL6, EGFR, SRC, p38, TRPC1 |
| SciDEX Target | View Target Profile (5 clinical trials) |
| SciDEX Hypotheses | Extracellular Matrix Stiffness Modulation |
| KG Connections | 960 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PIEZO1["PIEZO1"] -->|"associated"| neurodegeneration["neurodegeneration"]
PIEZO1["PIEZO1"] -->|"interacts"| KCNK2["KCNK2"]
PIEZO1["PIEZO1"] -->|"co discussed"| P2RX7["P2RX7"]
PIEZO1["PIEZO1"] -->|"co discussed"| DGAT1["DGAT1"]
PIEZO1["PIEZO1"] -->|"co discussed"| C3["C3"]
PIEZO1["PIEZO1"] -->|"co discussed"| GABRA1["GABRA1"]
KCNK2_1["KCNK2"] -->|"interacts"| PIEZO1["PIEZO1"]
BMAL1["BMAL1"] -->|"co discussed"| PIEZO1["PIEZO1"]
HK2["HK2"] -->|"co discussed"| PIEZO1["PIEZO1"]
MIRO1["MIRO1"] -->|"co discussed"| PIEZO1["PIEZO1"]
style PIEZO1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| TMEM16F | interacts_with | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Uterine Contractions | mediates | phenotype | 0.95 |
| Macrophage Efferocytosis | activates | process | 0.95 |
| Central Nervous System | involved_in | process | 0.95 |
| Macrophage Polarization | modulates | process | 0.95 |
| Stiffness Sensing | modulates | process | 0.95 |
| Mechanical Force Transduction | mediates | process | 0.95 |
| Muscle Mass | regulates | phenotype | 0.95 |
| Bone Mass | regulates | phenotype | 0.95 |
| Lymphatic Malformations | causes | disease | 0.95 |
| Uterine Contractions | involved_in | phenotype | 0.95 |
| Parturition | involved_in | process | 0.95 |
| Stiffness Sensing | mediates | process | 0.95 |
| Central Nervous System Physiology | regulates | process | 0.95 |
| Lymphatic Endothelial Cells | expressed_in | cell_type | 0.95 |
| Efferocytosis | activates | process | 0.95 |
| Hepatic Fibrosis | upregulates | disease | 0.95 |
| Macrophage Efferocytosis | associated_with | process | 0.95 |
| Liver Fibrosis Resolution | promotes | phenotype | 0.95 |
| Macrophage Efferocytosis | promotes | process | 0.95 |
| uterine contractions | associated_with | phenotype | 0.95 |
| mechanosensing | mediates | process | 0.95 |
| mechanical stimuli | associated_with | process | 0.95 |
| Tumor Cell Proliferation | regulates | process | 0.95 |
| Tumor Cell Migration | regulates | process | 0.95 |
| Tumor Cell Invasion | regulates | process | 0.95 |
| Tumor Angiogenesis | promotes | process | 0.95 |
| Tumor Progression | involved_in | process | 0.95 |
| Renal Fibrosis | implicated_in | disease | 0.95 |
| Mechanical Forces | involved_in | process | 0.92 |
| Tissue Stiffness | mediates | phenotype | 0.92 |
| Liver Fibrosis | protects_against | disease | 0.92 |
| parturition | mediates | process | 0.92 |
| liver fibrosis | therapeutic_target | disease | 0.92 |
| calcium influx | causes | phenotype | 0.90 |
| bone formation | activates | phenotype | 0.90 |
| bone mass | contributes_to | phenotype | 0.90 |
| podocyte injury | causes | phenotype | 0.90 |
| adipogenesis | activates | phenotype | 0.90 |
| FGF1 | causes | protein | 0.90 |
| macrophage polarization | regulates | phenotype | 0.90 |
| Labor Progression | associated_with | process | 0.90 |
| Periodontal Ligament Cells | expressed_in | cell_type | 0.90 |
| Liver Fibrosis | treats | disease | 0.90 |
| Mechanobiology | mediates | process | 0.90 |
| Calcium Influx | mediates | process | 0.90 |
| Efferocytosis | associated_with | biological_process | 0.90 |
| Liver Fibrosis | associated_with | disease | 0.90 |
| Cell Cycle Progression | regulates | process | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Mechanical Stimulation | activates | mechanism | 0.95 |
| Paeoniflorin | binds | compound | 0.95 |
| NF-κB | upstream_of | pathway | 0.95 |
| Paeoniflorin | therapeutic_target | compound | 0.93 |
| IL1A | activates | protein | 0.90 |
| CREB1 | regulates | protein | 0.90 |
| mechanical loading | activates | phenotype | 0.90 |
| tissue stiffness | activates | phenotype | 0.90 |
| artemisinin | inhibits | drug | 0.90 |
| Mechanical Stretch | activates | process | 0.90 |
| TNF | upregulates | entity | 0.90 |
| Tissue Stiffening | upregulates | process | 0.90 |
| Tissue Stiffness | activates | phenotype | 0.90 |
| ECM stiffness | activates | phenotype | 0.90 |
| h-725c62e9 | targets_gene | hypothesis | 0.90 |
| HNF4 | regulates | protein | 0.80 |
| ATF2 | regulates | protein | 0.80 |
| diabetic kidney disease | activates | disease | 0.80 |
| h-db6aa4b1 | targets | hypothesis | 0.80 |
| h-725c62e9 | targets | hypothesis | 0.80 |
| FAM38A | encodes | gene | 0.80 |
| p38 MAPK | regulates | protein | 0.80 |
| Inflammation | modulates | process | 0.75 |
| MECHANICAL_STIMULATION | activates | phenotype | 0.72 |
| Yoda1 | activates | drug | 0.72 |
| high fat diet | activates | phenotype | 0.70 |
| BAX | activates | gene | 0.70 |
| RUNX2 | activates | gene | 0.70 |
| cyclical_hydrostatic_pressure | activates | phenotype | 0.64 |
| KCNK2 | co_mentioned_with | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| TAZ | protects_against | gene | 0.60 |
| ORAI1 | regulates | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| CACNA1B | associated_with | gene | 0.60 |
| CACNA1C | expressed_in | gene | 0.60 |
| CFTR | associated_with | gene | 0.60 |
| TRPV4 | expressed_in | gene | 0.60 |
| KCNQ1 | associated_with | gene | 0.60 |
| TRPA1 | associated_with | gene | 0.60 |
| TRPV1 | associated_with | gene | 0.60 |
| TRPM7 | associated_with | gene | 0.60 |
| SCN5A | associated_with | gene | 0.60 |
| TNF | expressed_in | gene | 0.60 |
| TRPA1 | expressed_in | gene | 0.60 |
| TRPC1 | activates | gene | 0.60 |
| TRPA1 | regulates | gene | 0.60 |
| PIEZO2 | activates | gene | 0.60 |
| PIEZO2 | regulates | gene | 0.60 |
| P38 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Extracellular Matrix Stiffness Modulation | 0.427 | neurodegeneration | Microglia-astrocyte crosstalk amplificat |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.521
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.554
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Brain Capillary Ion Channels: Physiology and Channelopathies. [PMID:40748720] | Harraz OF, Hashad AM | Physiology (Bethesda) | 2026 | 1 |
| Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the [PMID:38838160] | Wang Y, Wang J, Zhang J, Wang Y, Wang Y, | Sci Adv | 2024 | 1 |
| Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central [PMID:37532007] | Zong B, Yu F, Zhang X, Pang Y, Zhao W, S | Ageing Res Rev | 2023 | 1 |
| Targeting extracellular matrix stiffness and mechanotransducers to improve cance [PMID:35331296] | Jiang Y, Zhang H, Wang J, Liu Y, Luo T, | J Hematol Oncol | 2022 | 1 |
| Mechanically activated ion channel Piezo1 modulates macrophage polarization and [PMID:34059671] | Atcha H, Jairaman A, Holt JR, Meli VS, N | Nat Commun | 2021 | 1 |
| Excessive compression induces cartilage endplate degeneration via the Piezo1/NAT [PMID:41175920] | Sun H, Wu Z, Zhang Y, Liu C, Gao D et al | Osteoarthritis Cartilage | 2026 | 0 |
| Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolis [PMID:41486513] | Ma J, Xie N, Wang Z, Liang X, Han Y et a | Adv Sci (Weinh) | 2026 | 0 |
| Insights into the role of the mechanosensitive Piezo1 channel and signaling mech [PMID:41544798] | Zhang M, Ge Y, Wang Z, Li H, Wang G et a | Neurosci Biobehav Rev | 2026 | 0 |
| Long-range chemical signalling in vivo is regulated by mechanical signals. [PMID:41555045] | Pillai EK, Mukherjee S, Gampl N, McGinn | Nat Mater | 2026 | 0 |
| The Glymphatic System and Meningeal Lymphatics: Current Understandings and Futur [PMID:41930354] | Sun H, Fan H, Zhou Y, Zhu H, Chen Y et a | MedComm (2020) | 2026 | 0 |
| Remote Magnetomechanical Neuromodulation Uncovers Therapeutic Mechanisms for All [PMID:41933910] | Wolters A, Signorelli L, Herff C, Gimple | Adv Sci (Weinh) | 2026 | 0 |
| A 3D-Printed Pulsatile Shear Stress Platform for Studying Endothelial Cell Mecha [PMID:41949555] | Romanov V, Li JV, Zhao F, Cheng D, Marti | Anal Chem | 2026 | 0 |
| Piezo channels in tumors. [PMID:41964669] | Zhang W, Dai L, Shi H | J Cancer Res Clin Oncol | 2026 | 0 |
| Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic [PMID:40653265] | ["Li R", "Xia J", "Shi C", "Zhang K", "Q | Journal of advanced research | 2026 | 0 |
| Piezo1 is a pathogenic gene and therapeutic target for neurological diseases. [PMID:40276938] | Wang H, Gou Z, Chen S, Lu L | The International journal of n | 2026 | 0 |
| Mechanosensitive channel Piezo1 in calcium dynamics: structure, function, and em [PMID:41195420] | Liu Y, Xu YQ, Long YY, Xiao H, Ma YY, Li | Frontiers in molecular bioscie | 2025 | 0 |
| PIEZO1: a mechanosensitive ion channel in the pathogenesis and pharmacotherapy o [PMID:41051683] | Gupta T, Singh TG, Singh R | Molecular biology reports | 2025 | 0 |
| Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion [PMID:38744281] | Zhang J, Li J, Hou Y, Lin Y, Zhao H, Shi | Cell | 2024 | 0 |
| The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing nov [PMID:35236990] | ["Costello S", "Shoemaker S", "Hobbs H", | Nature structural & molecular | 2022 | 0 |
| Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hep [PMID:36181398] | Li M, Zhang X, Wang M, Wang Y, Qian J, X | Cancer communications (London, | 2022 | 0 |